Skip to content
10-K

Annual Report

TAMIR BIOTECHNOLOGY, INC.

0001308411-13-000095

← back to feed
Filed
Apr 25, 2013 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2012 · Apr 25, 2013 217.36M sh
Shares Diluted FY 2012 · Jul 31, 2012 75.47M sh
Shares Diluted FY 2012 · Jul 31, 2011 93.58M sh
Capex FY 2012 · Jul 31, 2012 $14.82K
Capex FY 2012 · Jul 31, 2011 $0
Operating Cash Flow FY 2012 · Jul 31, 2012 −$345.34K
Operating Cash Flow FY 2012 · Jul 31, 2011 −$453.99K
Cash And Equivalents FY 2012 · Jul 31, 2012 $24.04K
Cash And Equivalents FY 2012 · Jul 31, 2011 $354.2K
Cash And Equivalents FY 2012 · Jul 31, 2010 $321.25K
Stockholders Equity FY 2012 · Jul 31, 2012 −$6.08M
Stockholders Equity FY 2012 · Jul 31, 2011 −$8.1M
Stockholders Equity FY 2012 · Jul 31, 2010 −$21.61M
Current Liabilities FY 2012 · Jul 31, 2012 $5.48M
Current Liabilities FY 2012 · Jul 31, 2011 $5.75M
Total Liabilities FY 2012 · Jul 31, 2012 $6.16M
Total Liabilities FY 2012 · Jul 31, 2011 $8.62M
Current Assets FY 2012 · Jul 31, 2012 $45.17K
Current Assets FY 2012 · Jul 31, 2011 $399.3K
Total Assets FY 2012 · Jul 31, 2012 $79.86K
Total Assets FY 2012 · Jul 31, 2011 $521.51K
Eps Diluted FY 2012 · Jul 31, 2012 $0.04
Eps Diluted restated FY 2012 · Jul 31, 2011 $0.05
Eps Basic FY 2012 · Jul 31, 2012 $0.04
Eps Basic FY 2012 · Jul 31, 2011 $0.29
Sga Expense FY 2012 · Jul 31, 2012 $307K
Sga Expense FY 2012 · Jul 31, 2011 −$244.19K
Rd Expense FY 2012 · Jul 31, 2012 $252.71K
Rd Expense FY 2012 · Jul 31, 2011 $857.72K
Net Income FY 2012 · Jul 31, 2012 $1.97M
Net Income FY 2012 · Jul 31, 2011 $14.14M
Operating Income FY 2012 · Jul 31, 2012 −$59.7K
Operating Income FY 2012 · Jul 31, 2011 $4.59M
Revenue FY 2012 · Jul 31, 2012 $500K
Revenue FY 2012 · Jul 31, 2011 $5.2M